ImmunityBio Inc. Common Stock vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $9.98 (market cap $10.51B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.55 (market cap $330.98M). The key difference: ImmunityBio Inc. Common Stock is far larger — about 31.8× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Roundhill S&P 500 0DTE Covered Call Strategy ETF for 54 Days on average.
| IBRX | XDTE | |
|---|---|---|
Market Cap | $10.51B | $330.98M |
Volume | 10,445,785 | 194,030 |
Sector | Health | Income / Options Overlay |
52-Week High | $11.55 | $44.76 |
52-Week Low | $1.98 | $36.00 |
Typical Hold Time | 0 Days | 54 Days |
Enterprise Value | $10.97B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →